Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation

The Journal of Nutritional Biochemistry
Gabriel DasilvaIsabel Medina

Abstract

Dietary intervention with ω-3 marine fatty acids may potentially modulate inflammation and oxidative stress markers related with CVD, metabolic syndrome and cancer. The aim of this study was to evaluate whether different proportions of ω-3 EPA and DHA intake provoke a modulation of the production of lipid mediators and then, an influence on different indexes of inflammation and oxidative stress in a controlled dietary animal experiment using Wistar rats. For such scope, a lipidomic SPE-LC-ESI-MS/MS approach previously developed was applied to determine lipid mediators profile in plasma samples. The effect of ω-3 fatty acids associated to different ratios EPA:DHA was compared with the effect exerted by ω-3 ALA supplementation from linseed oil and ω-6 LA from soybean oil. CRP showed a tendency to greater inflammatory status in all ω-3-fed animals. Interestingly, ratios 1:1 and 2:1 EPA:DHA evidenced a noteworthy healthy effect generating a less oxidative environment and modulating LOX and COX activities toward a decrease in the production of proinflammatory ARA eicosanoids and oxidative stress biomarkers from EPA and DHA. In addition, the ability of 1:1 and 2:1 fish oil diets to reduce lipid mediator levels was in concurrence with...Continue Reading

References

Aug 1, 1979·The Journal of Clinical Investigation·T Tsukamoto, M Sonenberg
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Apr 26, 2008·Nature Reviews. Immunology·Charles N SerhanThomas E Van Dyke
Jun 28, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Doriane RichardFrancesco Visioli
Oct 1, 2008·Journal of Internal Medicine·J P CasasM B Pepys
Oct 28, 2008·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Marika MassaroRaffaele De Caterina
Feb 27, 2009·The Journal of Nutrition·William S HarrisJay Whelan
Jun 12, 2009·The American Journal of Clinical Nutrition·Mark BouwensLydia A Afman
Aug 13, 2009·Journal of Lipid Research·Gregory C ShearerJohn W Newman
Sep 29, 2009·Biochimica Et Biophysica Acta·Pablo Perez-MartinezJose Lopez-Miranda
Mar 5, 2010·Renal Failure·Ali Borazan, Dogan Nasir Binici
Nov 17, 2010·Analytical and Bioanalytical Chemistry·Carlos Ferreiro-VeraMaría Dolores Luque de Castro
Mar 3, 2011·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Jodi C McDanielAnna Nicolaou
Aug 9, 2011·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Mattia Di NunzioAlessandra Bordoni
Aug 26, 2011·Prostaglandins & Other Lipid Mediators·Emily R GreeneDipak Panigrahy
Sep 23, 2011·The Journal of Nutritional Biochemistry·Andrew P NeilsonDean E Brenner
Nov 9, 2011·The International Journal of Biochemistry & Cell Biology·Catherine GarrelKaïs H Al-Gubory
Nov 25, 2011·European Journal of Clinical Nutrition·I ReindersT-P Tuomainen
Feb 3, 2012·Archives of Pharmacal Research·Chang Hoon Lee
Jul 24, 2012·The Journal of Nutritional Biochemistry·Viral BrahmbhattNabil Bosco
Sep 4, 2012·Free Radical Biology & Medicine·Karen A Massey, Anna Nicolaou
Nov 20, 2012·Free Radical Biology & Medicine·Lucía MéndezIsabel Medina

❮ Previous
Next ❯

Citations

Aug 17, 2016·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Ann N Biesboer, Nancy A Stoehr
Sep 30, 2016·Reproduction, Fertility, and Development·Naglaa F Khedr
Dec 22, 2016·Current Opinion in Clinical Nutrition and Metabolic Care·Lucy V NorlingJesmond Dalli
Feb 14, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Laura E Gutiérrez-PliegoRoxana Valdés-Ramos
Nov 27, 2017·Metabolomics : Official Journal of the Metabolomic Society·Junjie ZhangChun Cai
Jun 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gabriel DasilvaIsabel Medina
Sep 8, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Zahid Rasul NiaziCyril Auger
Apr 21, 2020·Metabolomics : Official Journal of the Metabolomic Society·Jeremy P KoelmelJohn A Bowden
Jan 12, 2021·Journal of Agricultural and Food Chemistry·Zongyuan WuHong Chen
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wale Johnson Adeyemi, Luqman Aribidesi Olayaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.